TABLE 1.
Antibiotic(s)a | MIC (μg/ml) for E. coli strainb:
|
||||||
---|---|---|---|---|---|---|---|
V541 wt | 26R793 trc (VIM-1 + AmpC) | 26R793 | DH5α trf (VIM-1 + AmpC) | DH5α (VIM-2) | DH5α (LAT-1) | DH5α | |
Ampicillin | >256 | >256 | 2 | >256 | >256 | >256 | 1 |
Ticarcillin | >256 | >256 | 1 | >256 | >256 | >256 | 0.5 |
Ticarcillin + CLA | >256 | >256 | 1 | >256 | >256 | >256 | 1 |
Piperacillin | >256 | >256 | 1 | >256 | 128 | >256 | 0.5 |
Piperacillin + TAZ | >256 | >256 | 0.5 | >256 | 128 | 64 | 0.25 |
Piperacillin + Ro | >256 | 256 | 1 | 256 | 128 | 2 | 0.5 |
Cefoxitin | >128 | >128 | 2 | >128 | >128 | >128 | 2 |
Cefoxitin + Ro | >128 | 64 | 2 | 64 | >128 | 2 | 2 |
Cefotaxime | 128 | >128 | 0.12 | 128 | 32 | 32 | ≤0.06 |
Cefotaxime + Ro | 128 | 128 | ≤0.06 | 64 | 32 | ≤0.06 | ≤0.06 |
Cefazidime | >128 | >128 | 0.12 | >128 | 64 | 128 | 0.12 |
Ceftazidime + Ro | >128 | >128 | 0.12 | >128 | 64 | 0.5 | 0.12 |
Cefepime | 64 | 32 | ≤0.06 | 32 | 2 | 0.5 | ≤0.06 |
Cefepime + Ro | 64 | 32 | ≤0.06 | 32 | 1 | ≤0.06 | ≤0.06 |
Aztreonam | 8 | 4 | ≤0.06 | 4 | 0.25 | 16 | ≤0.06 |
Aztreonam + Ro | 0.25 | 0.12 | 0.12 | 0.12 | 0.25 | 0.12 | ≤0.06 |
Imipenem | 8 | 8 | ≤0.06 | 8 | 2 | 0.5 | ≤0.06 |
Imipenem + Ro | 8 | 8 | ≤0.06 | 8 | 2 | ≤0.06 | ≤0.06 |
Meropenem | 2 | 2 | ≤0.06 | 1 | 1 | 0.12 | ≤0.06 |
Meropenem + Ro | 2 | 2 | ≤0.06 | 1 | 1 | ≤0.06 | ≤0.06 |
CLA, clavulanic acid (2 μg/ml); TAZ, tazobactam (4 μg/ml); Ro, Ro 48-1220 (10 μg/ml).
wt, wild-type; trc, transconjugant; trf, transformant. The β-lactamas(es) produced by each strain is in parentheses.